I. Semaglutide: A New Kid on the Block for Nonalcoholic Steatohepatitis, but a Long Way to Go for India: Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, Sanyal AJ, Sejling AS, Harrison SA; NN9931-4296 Investigators. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. N Engl J Med. 2021 Mar 25;384:1113–1124. https://doi.org/10.1056/NEJMoa2028395. Epub 2020 Nov 13. PMID: 33185364.

Publication date: July–August 2021Source: Journal of Clinical and Experimental Hepatology, Volume 11, Issue 4Author(s): Pankaj Puri
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research